TRADING UPDATES: OptiBiotix Health hails 2025 revenue surge
1st Apr 2026 14:29
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 9.25p on 04-06-2026 at 18:35:08 |
|---|---|
| Change | 0.00p 0% |
| Buy | 9.50p |
| Sell | 9.00p |
| Last Trade: | Sell 57,647.00 at 9.13p |
| Day's Volume: | 150,866 |
| Last Close: | 9.25p |
| Open: | 9.25p |
| ISIN: | GB00BGKPX309 |
| Day's Range | 9.25p - 9.25p |
| 52wk Range: | 8.50p - 14.30p |
| Market Capitalisation: | £31.06m |
| VWAP: | 9.190533p |
| Shares in Issue: | 335.73m |
Sector: Brokerage Services
Listed In: FTSE AIM All-Share,
Cavendish Plc (CAV) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 57,647 | 9.13p | Ordinary |
14:46:30 - 04-Jun-26 |
| Sell* | 59,400 | 9.13p | Ordinary |
13:33:41 - 04-Jun-26 |
| Buy* | 6,309 | 9.40p | Ordinary |
12:17:18 - 04-Jun-26 |
| Buy* | 903 | 9.40p | Ordinary |
11:48:40 - 04-Jun-26 |
| Buy* | 26,595 | 9.40p | Ordinary |
10:26:08 - 04-Jun-26 |
| Buy* | 11 | 9.50p | SI Trade |
08:30:12 - 04-Jun-26 |
| Unknown* | 0 | 9.00p | SI Trade |
08:30:12 - 04-Jun-26 |
| Buy* | 1 | 9.50p | Ordinary |
08:30:10 - 04-Jun-26 |
| Sell* | 370 | 9.00p | Ordinary |
14:39:03 - 03-Jun-26 |
| Sell* | 2,600 | 9.00p | Ordinary |
13:04:46 - 03-Jun-26 |
Cavendish Plc (CAV) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 10th Apr 2026 3:18 pm | RNS | Directors Dealings |
| 1st Apr 2026 7:00 am | RNS | Full Year Trading Update |
| 26th Feb 2026 3:38 pm | RNS | Holding(s) in Company |
| 3rd Feb 2026 2:30 pm | RNS | Directors Dealings |
| 18th Dec 2025 9:08 am | RNS | Directors Dealings |
| 15th Dec 2025 4:15 pm | RNS | Director Dealing: Correction |
| 11th Dec 2025 4:00 pm | RNS | Director Dealing |
| 2nd Dec 2025 7:00 am | RNS | Block Admission Return and Total Voting Rights |
| 21st Nov 2025 4:45 pm | RNS | Holding(s) in Company |
| 30th Oct 2025 7:00 am | RNS | 2026 Interim Results |